-+ 0.00%
-+ 0.00%
-+ 0.00%

Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?

Benzinga·12/15/2024 15:00:38
Listen to the news

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?

  1. Patterson Companies, Inc. (NASDAQ:PDCO) stock rocketed 35.60% after the company announced it entered into a definitive agreement to be acquired by Patient Square Capital for approximately $4.1 billion.
  2. NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares jumped 34.55% after the company announced topline data from its Phase 3 BROADWAY trial of Obicetrapib.
  3. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) gained 21.38% last week following a report from Sky News indicating that Sycamore Partners has approached various potential lenders to fund a possible acquisition of the company.
  4. NovoCure Limited (NASDAQ:NVCR) stock rose 19.49%. Piper Sandler maintained an Overweight rating and raised the price target to $42.
  5. RH (NYSE:RH) shares surged 18.60% after the company reported quarterly results and raised its guidance. Also, Baird maintained a Neutral rating on the stock and raised its price target from $300 to $400.
  6. Pactiv Evergreen Inc. (NASDAQ:PTVE) stock upped 17.71% after the company announced it would merge with Novolex, in which Pactiv shareholders would receive $18.00 per share in cash.
  7. Comstock Resources, Inc. (NYSE:CRK) shares escalated 15.70%.
  8. ReNew Energy Global plc (NASDAQ:RNW) stock rose 15.47% after the company announced it received a $7.07 share buyout proposal from a consortium including Masdar, CPP Investments, ADIA and founder Sumant Sinha to acquire the remaining share capital.
  9. Alaska Air Group, Inc. (NYSE:ALK) stock was up 15.15% after the company unveiled “Alaska Accelerate,” a strategy to boost profitability and issued a strong FY25 outlook. Analysts boosted the price target on the stock.
  10. Stevanato Group S.p.A. (NYSE:STVN) stock upped 13.82%. Wolfe Research initiates coverage with an Outperform rating and a price forecast of $28.

Also Read:

Image via Shutterstock